Rituximab for refractory and relapsing thrombotic thrombocytopenic purpura

被引：0
|
作者：
Knoebl, P. N. [1 ]
Distelmaier, P. [1 ]
Koder, S. [1 ]
Schellongowski, P. [1 ]
Quehenberger, P. [2 ]
机构：
[1] Med Univ Vienna, Med 1, Vienna, Austria
[2] Med Univ Vienna, Lab Med, Vienna, Austria
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-077
引用
下载
收藏
页码：959 / 959
页数：1
相关论文
共 50 条
  • [21] Laparoscopic splenectomy in patients with refractory or relapsing thrombotic thrombocytopenic purpura
    Schwartz, J
    Eldor, A
    Szold, A
    ARCHIVES OF SURGERY, 2001, 136 (11) : 1236 - 1238
  • [22] Daratumumab for frequently relapsing and refractory immune thrombotic thrombocytopenic purpura
    van den Berg, J.
    Hovinga, J. A. Kremer
    Holbro, A.
    Studt, J. -D.
    SWISS MEDICAL WEEKLY, 2021, 151 : 18 - 18
  • [23] Rituximab in three cases of refractory thrombotic thrombocytopenic purpura.
    Alcaraz, J
    González-García, C
    Majado, MJ
    Pérez, R
    Molina, JA
    Tamayo, M
    Moreno, M
    Morales, A
    BLOOD, 2005, 106 (11) : 82B - 82B
  • [24] A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab
    Kirui, N.
    Sokwala, A.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2016, 106 (07): : 54 - 56
  • [25] Rituximab for Thrombotic Thrombocytopenic Purpura
    Kivity, Shaye
    Agmon-Levin, Nancy
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (07): : 436 - 437
  • [26] Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura
    Ruefer, Axel
    Brodmann, Doreen
    Gregor, Michael
    Hovinga, Fohanna A. Kremer
    Laemmle, Bernhard
    Wuillemin, Walter A.
    SWISS MEDICAL WEEKLY, 2007, 137 (37-38) : 518 - 524
  • [27] EFFECTIVENESS OF CRYOSUPERNATANT THERAPY IN REFRACTORY AND CHRONIC RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA
    OBRADOR, GT
    ZEIGLER, ZR
    SHADDUCK, RK
    ROSENFELD, CS
    HANRAHAN, JB
    AMERICAN JOURNAL OF HEMATOLOGY, 1993, 42 (02) : 217 - 220
  • [28] Another beneficial effect of rituximab on refractory and relapsing thrombotic thrombocytopenic purpura: The role of interleukin-12 suppression?
    Park, Se Jin
    Shin, Jae Il
    CRITICAL CARE MEDICINE, 2012, 40 (04) : 1391 - 1391
  • [29] Splenectomy relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura
    Hovinga, JAK
    Studt, JD
    Biasiutti, FD
    Solenthaler, M
    Alberio, L
    Zwicky, C
    Fontana, S
    Taleghani, BM
    Tobler, A
    Lämmle, B
    HAEMATOLOGICA, 2004, 89 (03) : 320 - 324
  • [30] Severe opportunistic infections after rituximab treatment for refractory or relapsing thrombotic thrombocytopenic purpura. A case report
    Verga, L.
    Carrer, A.
    Scollo, C.
    Perego, A.
    Borin, L.
    Casaroli, I
    Pezzatti, S.
    Elli, E.
    Fedeli, M.
    Rossini, F.
    Pogliani, E. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 153 - 153
12345